Lori Anne Kunkel - Net Worth and Insider Trading
Lori Anne Kunkel Net Worth
The estimated net worth of Lori Anne Kunkel is at least $6,582 dollars as of 2024-09-20. Lori Anne Kunkel is the Director of Curis Inc and owns about 1,110 shares of Curis Inc (CRIS) stock worth over $6,582. Lori Anne Kunkel is also the Director of Loxo Oncology Inc and owns about 0 shares of Loxo Oncology Inc (LOXO) stock worth over $0. Details can be seen in Lori Anne Kunkel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lori Anne Kunkel has not made any transactions after 2019-01-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lori Anne Kunkel
Lori Anne Kunkel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lori Anne Kunkel owns 5 companies in total, including Nurix Therapeutics Inc (NRIX) , ORIC Pharmaceuticals Inc (ORIC) , and Curis Inc (CRIS) among others .
Click here to see the complete history of Lori Anne Kunkel’s form 4 insider trades.
Insider Ownership Summary of Lori Anne Kunkel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NRIX | Nurix Therapeutics Inc | 2020-07-23 | director |
| ORIC | ORIC Pharmaceuticals Inc | 2020-06-09 | director |
| CRIS | Curis Inc | 2019-01-23 | director |
 | | 2017-04-12 | director |
| | 2019-02-15 | director |
Lori Anne Kunkel Latest Holdings Summary
Lori Anne Kunkel currently owns a total of 2 stocks. Among these stocks, Lori Anne Kunkel owns 1,110 shares of Curis Inc (CRIS) as of January 23, 2019, with a value of $6,582 and a weighting of 100%. Lori Anne Kunkel also owns 0 shares of Loxo Oncology Inc (LOXO) as of October 1, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Lori Anne Kunkel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRIS | Curis Inc | 2019-01-23 | 1,110 | 5.93 | 6,582 |
| LOXO | Loxo Oncology Inc | 2018-10-01 | 0 | 234.66 | 0 |
Holding Weightings of Lori Anne Kunkel
Lori Anne Kunkel Form 4 Trading Tracker
According to the SEC Form 4 filings, Lori Anne Kunkel has made a total of 0 transactions in Curis Inc (CRIS) over the past 5 years. The most-recent trade in Curis Inc is the sale of 740 shares on January 23, 2019, which brought Lori Anne Kunkel around $15,540.
According to the SEC Form 4 filings, Lori Anne Kunkel has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 5,000 shares on October 1, 2018, which brought Lori Anne Kunkel around $851,850.
Insider Trading History of Lori Anne Kunkel
- 1
Lori Anne Kunkel Trading Performance
Lori Anne Kunkel Ownership Network
Lori Anne Kunkel Owned Company Details
What does Nurix Therapeutics Inc do?
Who are the key executives at Nurix Therapeutics Inc?
Lori Anne Kunkel is the director of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and Chief Scientific Officer Gwenn Hansen .
Nurix Therapeutics Inc (NRIX) Insider Trades Summary
Over the past 18 months, Lori Anne Kunkel made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 45,727 shares made by Christine Ring , a net sale of 76,829 shares made by Houte Hans Van , and a net sale of 12,402 shares made by Gwenn Hansen .
In summary, during the past 3 months, insiders sold 62,735 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 62,735 shares. During the past 18 months, 135,300 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 135,300 shares.
Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nurix Therapeutics Inc Insider Transactions
Lori Anne Kunkel Mailing Address
Above is the net worth, insider trading, and ownership report for Lori Anne Kunkel. You might contact Lori Anne Kunkel via mailing address: C/o Pharmacyclics, Inc., 995 East Arques Avenue, Sunnyvale Ca 94085.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
